ONC's latest rules give way to greater data sharing, but data quality issues remain

The U.S. Food and Drug Administration's validation requirements process for drug development is a good model for healthcare artificial intelligence governance, explains Michael Abrams, managing partner at Numerof & Associates.

Eitan Okun, head of the Paul Feder Laboratory for Alzheimer's Disease Research at Bar-Ilan University, discusses the lab's study on the mechanistic link between pregnancy with a Down syndrome fetus and an elevated risk of maternal cognitive decline.

Switching cardiology patients to Bluetooth-enabled medical devices that send data to patient portals is helping to reduce chronic care complexities, says Sutter Health CCIO Dr. Richard Milani and Patient Experience R&D lead Trevor Berceau.